|
NOP14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.772600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.590000E-02 |
| Normal-vs-Stage2 |
8.281000E-01 |
| Normal-vs-Stage3 |
5.669500E-02 |
| Normal-vs-Stage4 |
5.990800E-01 |
| Stage1-vs-Stage2 |
1.593200E-01 |
| Stage1-vs-Stage3 |
5.70229999999894E-05 |
| Stage1-vs-Stage4 |
2.804200E-02 |
| Stage2-vs-Stage3 |
2.443800E-01 |
| Stage2-vs-Stage4 |
8.438800E-01 |
| Stage3-vs-Stage4 |
2.753000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.267600E-01 |
| Normal-vs-AfricanAmerican |
9.112800E-01 |
| Normal-vs-Asian |
2.689000E-01 |
| Caucasian-vs-AfricanAmerican |
9.612200E-01 |
| Caucasian-vs-Asian |
1.827040E-01 |
| AfricanAmerican-vs-Asian |
1.738000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.672800E-01 |
| Normal-vs-Female |
4.426200E-01 |
| Male-vs-Female |
3.443800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.997960E-01 |
| Normal-vs-Age(41-60Yrs) |
5.257400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.470200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.910600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.655570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.209800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.165800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.205800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.378800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.041800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.120400E-03 |
| Normal-vs-Grade 2 |
1.646190E-01 |
| Normal-vs-Grade 3 |
4.971800E-01 |
| Normal-vs-Grade 4 |
3.908200E-01 |
| Grade 1-vs-Grade 2 |
1.198970E-01 |
| Grade 1-vs-Grade 3 |
1.992270E-02 |
| Grade 1-vs-Grade 4 |
2.929900E-02 |
| Grade 2-vs-Grade 3 |
2.084400E-02 |
| Grade 2-vs-Grade 4 |
3.985700E-02 |
| Grade 3-vs-Grade 4 |
6.757600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.111870E-02 |
| Normal-vs-ccB subtype |
1.314770E-01 |
| ccA subtype-vs-ccB subtype |
2.07039999999825E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.210600E-01 |
| Normal-vs-N1 |
7.836400E-01 |
| N0-vs-N1 |
8.022600E-01 |
|
|
